Available 24/7 for Urgent On-Site or Virtual Consulting

FDA Inspections

Consulting and Compliance

Day: September 25, 2025

Inspections

In Vitro Diagnostics: Navigating Your First FDA Inspection
ByFDA Inspections Team September 25, 2025September 25, 2025

Facing your first FDA inspection for in vitro diagnostics can be daunting. This comprehensive guide provides the essential framework for success, covering everything from pre-inspection readiness and building a robust Quality Management System to managing the on-site audit and responding effectively to observations. We break down the key regulations, highlight common pitfalls in design controls and CAPA, and provide actionable strategies to ensure your team is prepared, confident, and compliant. Use this guide to transform regulatory hurdles into opportunities to strengthen your quality culture.

Read More In Vitro Diagnostics: Navigating Your First FDA Inspection
Inspections

Top 5 AI Tools Transforming FDA Compliance Automation in Regulated Industries
ByFDA Inspections Team September 25, 2025September 25, 2025

In today’s complex regulatory landscape, manual compliance is no longer enough. The risk of human error, costly delays, and FDA scrutiny is too high. This guide explores the transformative power of artificial intelligence in regulatory affairs. We break down the top 5 AI tools for FDA compliance automation that are helping life sciences companies enhance their Quality Management Systems, streamline document control, and prepare for audits with confidence. Learn how you can leverage these technologies to ensure compliance.

Read More Top 5 AI Tools Transforming FDA Compliance Automation in Regulated Industries
Inspections

2025 FDA Inspection Trends in the Pharmaceutical Industry
ByFDA Inspections Team September 25, 2025September 25, 2025

The regulatory landscape for pharmaceuticals is constantly evolving. As we move into 2025, the FDA is adapting its strategies to address new technologies and global challenges. This guide explores the critical FDA inspection trends in pharmaceuticals that every company must be aware of. We cover the intensified focus on data integrity, the normalization of remote and hybrid inspections, and heightened scrutiny on supply chain security. Prepare your organization for success by understanding these key trends.

Read More 2025 FDA Inspection Trends in the Pharmaceutical Industry
News

Recent FDA Recalls in Dietary Supplements: Lessons Learned
ByFDA Inspections Team September 25, 2025September 25, 2025

The dietary supplement market is booming, but so is regulatory scrutiny. An FDA recall can devastate a brand’s reputation and bottom line overnight. Many of these recalls are not accidents but the result of systemic failures in quality control and compliance. This article explores the most common reasons behind recent FDA recalls in dietary supplements, from undeclared pharmaceutical ingredients to microbial contamination. We will analyze real-world scenarios and provide actionable lessons to help you strengthen your quality systems and avoid becoming another statistic.

Read More Recent FDA Recalls in Dietary Supplements: Lessons Learned
Inspections

Pre-Approval Inspection Readiness for Biologics Manufacturers
ByFDA Inspections Team September 25, 2025September 25, 2025

Navigating a pre-approval inspection for biologics is the final, critical hurdle before commercialization. This pivotal assessment by the FDA determines if your manufacturing processes, facilities, and quality systems can consistently produce a safe and effective product. This guide offers an in-depth roadmap for 2025, focusing on the unique complexities of biologics. We cover everything from establishing a bulletproof Quality Management System (QMS) and ensuring data integrity to preparing your facility and team for intense regulatory scrutiny. Learn the key strategies to demonstrate control, avoid common pitfalls, and confidently prove your readiness for market approval.

Read More Pre-Approval Inspection Readiness for Biologics Manufacturers
Inspections

FDA Cosmetic Labeling Requirements for 2025: What’s Changed?
ByFDA Inspections Team September 25, 2025September 25, 2025

Navigating the new cosmetic labeling FDA requirements for 2025 is critical for market success and avoiding regulatory action. With the full implementation of the Modernization of Cosmetics Regulation Act (MoCRA), companies face significant changes in how they declare allergens, list contact information, and ensure label transparency. This comprehensive guide breaks down the essential updates, providing actionable insights to help you align your product labels with the latest standards to remain compliant and competitive.

Read More FDA Cosmetic Labeling Requirements for 2025: What’s Changed?
Inspections

Medical Device GxP Audit Checklist for 2025: Are You Inspection-Ready?
ByFDA Inspections Team September 25, 2025September 25, 2025

In the highly regulated medical device industry, GxP compliance is not just a best practice—it is a fundamental requirement for market access and patient safety. With regulatory scrutiny intensifying in 2025, a proactive approach to quality is essential. This article provides a comprehensive medical device GxP audit checklist designed to help manufacturers prepare for FDA inspections and other regulatory assessments. From your Quality Management System to CAPA procedures and post-market surveillance, we cover every critical area.

Read More Medical Device GxP Audit Checklist for 2025: Are You Inspection-Ready?
Inspections

FDA Audits for Cosmetic Manufacturers: Compliance Essentials You Can’t Ignore
ByFDA Inspections Team September 25, 2025September 25, 2025

Are you prepared for FDA audits for cosmetic manufacturers? With the new MoCRA regulations, the FDA has enhanced authority to inspect facilities and enforce compliance. This guide covers the essentials you can’t ignore, from understanding GMP requirements and maintaining meticulous records to handling adverse event reporting. Learn how to prepare for an inspection, respond to observations, and build a culture of quality that protects your brand and consumers. Stay ahead of regulatory changes and avoid costly penalties.

Read More FDA Audits for Cosmetic Manufacturers: Compliance Essentials You Can’t Ignore
Inspections

GDP Compliance in Biologics Logistics: A Complete Guide for 2025
ByFDA Inspections Team September 25, 2025September 25, 2025

Discover the essentials of Good Distribution Practice (GDP) for the biologics supply chain in our comprehensive 2025 guide. This article explores the critical challenges of maintaining GDP compliance in biologics logistics, from stringent temperature control and real-time monitoring to robust data integrity and secure transportation. Learn how to navigate regulatory expectations, validate your processes, and implement a resilient Quality Management System (QMS) to prevent costly compliance failures and ensure product safety.

Read More GDP Compliance in Biologics Logistics: A Complete Guide for 2025
Inspections

Preparing for a Virtual FDA Inspection: A Step-by-Step Industry Guide
ByFDA Inspections Team September 25, 2025September 25, 2025

The rise of remote work has transformed regulatory oversight, making virtual FDA inspections a new standard. Preparing for a virtual FDA inspection requires a proactive strategy that addresses technology, documentation, and team readiness. This guide provides a detailed roadmap for manufacturers to navigate this digital-first approach. We cover everything from setting up secure data-sharing platforms to training your staff for live-streamed facility tours and remote interviews, ensuring you can confidently demonstrate compliance.

Read More Preparing for a Virtual FDA Inspection: A Step-by-Step Industry Guide

FDA Inspections

Your trusted partner for FDA compliance and inspection readiness. With former ex-FDA’ers on our team, we provide the expertise and confidence you need to succeed.

Services

Industries

© 2024 FDA Inspections. All rights reserved.

THE IMMERSIVE FDA INSPECTION EXPERIENCE →

WARNING LETTERS 483 OBSERVATIONS